A detailed history of California Public Employees Retirement System transactions in Abb Vie Inc. stock. As of the latest transaction made, California Public Employees Retirement System holds 5,543,290 shares of ABBV stock, worth $998 Million. This represents 0.78% of its overall portfolio holdings.

Number of Shares
5,543,290
Previous 6,248,879 11.29%
Holding current value
$998 Million
Previous $1.07 Billion 2.13%
% of portfolio
0.78%
Previous 0.79%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$163.84 - $199.33 $116 Million - $141 Million
-705,589 Reduced 11.29%
5,543,290 $1.09 Billion
Q2 2024

Aug 14, 2024

SELL
$154.79 - $180.76 $66.7 Million - $77.9 Million
-430,689 Reduced 6.45%
6,248,879 $1.07 Billion
Q1 2024

Apr 30, 2024

BUY
$159.82 - $182.1 $95.6 Million - $109 Million
598,033 Added 9.83%
6,679,568 $1.22 Billion
Q4 2023

Feb 01, 2024

SELL
$137.6 - $154.97 $13 Million - $14.6 Million
-94,355 Reduced 1.53%
6,081,535 $942 Million
Q3 2023

Nov 02, 2023

BUY
$133.59 - $154.65 $14.1 Million - $16.4 Million
105,888 Added 1.74%
6,175,890 $921 Million
Q2 2023

Aug 09, 2023

SELL
$132.51 - $164.9 $22 Million - $27.4 Million
-166,204 Reduced 2.67%
6,070,002 $818 Million
Q1 2023

May 12, 2023

SELL
$144.61 - $166.54 $71.5 Million - $82.3 Million
-494,125 Reduced 7.34%
6,236,206 $994 Million
Q4 2022

Feb 08, 2023

BUY
$138.31 - $165.87 $53.9 Million - $64.7 Million
389,877 Added 6.15%
6,730,331 $1.09 Billion
Q3 2022

Nov 09, 2022

BUY
$134.21 - $153.93 $84.7 Million - $97.1 Million
631,064 Added 11.05%
6,340,454 $851 Million
Q2 2022

Aug 10, 2022

BUY
$137.62 - $174.96 $40.5 Million - $51.5 Million
294,441 Added 5.44%
5,709,390 $874 Million
Q1 2022

May 04, 2022

BUY
$131.98 - $163.75 $195 Million - $242 Million
1,480,867 Added 37.64%
5,414,949 $878 Million
Q4 2021

Feb 10, 2022

SELL
$107.43 - $135.93 $19 Million - $24.1 Million
-177,041 Reduced 4.31%
3,934,082 $533 Million
Q3 2021

Nov 10, 2021

BUY
$106.4 - $120.78 $10.8 Million - $12.3 Million
101,611 Added 2.53%
4,111,123 $443 Million
Q2 2021

Aug 13, 2021

SELL
$105.21 - $117.21 $7.81 Million - $8.7 Million
-74,255 Reduced 1.82%
4,009,512 $452 Million
Q1 2021

May 14, 2021

SELL
$102.3 - $112.62 $36.4 Million - $40 Million
-355,337 Reduced 8.0%
4,083,767 $442 Million
Q4 2020

Feb 02, 2021

BUY
$80.49 - $108.67 $16.2 Million - $21.8 Million
200,682 Added 4.73%
4,439,104 $476 Million
Q3 2020

Nov 05, 2020

BUY
$85.91 - $100.83 $13.2 Million - $15.5 Million
153,388 Added 3.75%
4,238,422 $371 Million
Q2 2020

Aug 12, 2020

BUY
$73.37 - $98.18 $49.9 Million - $66.7 Million
679,641 Added 19.96%
4,085,034 $401 Million
Q1 2020

May 12, 2020

SELL
$64.5 - $97.79 $9.84 Million - $14.9 Million
-152,509 Reduced 4.29%
3,405,393 $259 Million
Q4 2019

Jan 27, 2020

SELL
$72.13 - $90.25 $620,318 - $776,150
-8,600 Reduced 0.24%
3,557,902 $315 Million
Q3 2019

Oct 31, 2019

BUY
$62.98 - $75.72 $40.6 Million - $48.8 Million
644,078 Added 22.04%
3,566,502 $270 Million
Q2 2019

Aug 15, 2019

SELL
$65.7 - $83.98 $7.53 Million - $9.63 Million
-114,635 Reduced 3.77%
2,922,424 $213 Million
Q1 2019

May 03, 2019

BUY
$77.14 - $90.79 $2.57 Million - $3.03 Million
33,344 Added 1.11%
3,037,059 $245 Million
Q4 2018

Feb 08, 2019

SELL
$77.85 - $96.01 $16.8 Million - $20.7 Million
-215,431 Reduced 6.69%
3,003,715 $277 Million
Q3 2018

Nov 13, 2018

SELL
$88.91 - $98.84 $38.9 Million - $43.3 Million
-437,782 Reduced 11.97%
3,219,146 $304 Million
Q2 2018

Aug 15, 2018

SELL
$89.78 - $106.23 $28.9 Million - $34.2 Million
-322,324 Reduced 8.1%
3,656,928 $339 Million
Q1 2018

May 11, 2018

SELL
$92.01 - $123.21 $25.9 Million - $34.7 Million
-281,510 Reduced 6.61%
3,979,252 $377 Million
Q4 2017

Feb 06, 2018

BUY
$89.56 - $98.21 $12 Million - $13.2 Million
134,106 Added 3.25%
4,260,762 $412 Million
Q3 2017

Nov 15, 2017

BUY
$69.85 - $89.22 $288 Million - $368 Million
4,126,656
4,126,656 $367 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.